MARKET OVERVIEW
The global neurology devices market, valued at USD 14.4 billion in 2024, is projected to surge to USD 26.6 billion by 2033—growing at a robust CAGR of 6.72 from 2025 to 2033. This growth is driven by the rising prevalence of neurological disorders (like epilepsy, Alzheimer’s, stroke), accelerated technological advancements in device innovation, and an aging global population fueling demand for advanced diagnostic and therapeutic tools.
STUDY ASSUMPTION YEARS
- BASE YEAR: 2024
- HISTORICAL YEAR: 2019–2024
- FORECAST YEAR: 2025–2033
NEUROLOGY DEVICES MARKET KEY TAKEAWAYS
- Market size & growth: USD 14.4 B in 2024 → USD 26.6 B by 2033, at a 6.72% CAGR
- Product dominance: Neurostimulation devices hold the largest share among products
- End user leadership: Hospitals lead the market, followed by ambulatory surgery centers and neurology clinics
- Regional performance: North America holds the largest market share, supported by advanced healthcare infrastructure
- Primary growth drivers: Increasing neurological disorders, a growing geriatric population, technological innovation, and favorable government initiatives supporting device adoption
MARKET GROWTH FACTORS
1. Rising Prevalence of Neurological Disorders & Aging Population
Neurological disorders like Alzheimer’s, epilepsy, stroke, Parkinson’s, and various forms of dementia are on the rise around the world. The World Health Organization reports that diabetic neuropathy affected around 206 million people in 2021, which really highlights the urgent need for better neurological health solutions. As our global population ages, the demand for care increases, especially since older adults are more susceptible to neurodegenerative diseases. This growing trend is driving the need for better diagnostic and therapeutic devices, which in turn is pushing the market forward and inspiring the creation of more precise and adaptable technologies in neurology.
2. Technological Innovation & Minimally Invasive Therapies
Recent advancements in neurotechnology—think AI-assisted imaging, neuro-robotics, wireless implants, closed-loop stimulators, and wearable monitoring systems—are truly transforming how care is delivered. For instance, the neurostimulation devices market was valued at a whopping USD 9.6 billion in 2024 and is projected to soar to USD 22 billion by 2033, with a compound annual growth rate of 9.21%. These innovations allow for non-invasive or minimally invasive treatments, which not only shorten hospital stays but also enhance patient outcomes. The integration of closed-loop AI systems and wearable neuromodulators is making therapies more tailored and effective.
3. Policy Support & Healthcare Infrastructure Expansion
Government initiatives that bolster neurology infrastructure and favorable reimbursement policies are really helping to boost the adoption of these devices. Investments in healthcare facilities and research funding are driving innovation and making these technologies more accessible. North America is leading the way, thanks to its advanced infrastructure and supportive regulations. Meanwhile, countries like South Korea, with an impressive CAGR of around 8.2%, are ramping up their infrastructure through public-private partnerships to improve access, while also streamlining regulatory pathways for AI-based diagnostics to facilitate market entry.
Request for a sample copy of this report: https://www.imarcgroup.com/neurology-devices-market/requestsample
MARKET SEGMENTATION
Breakup by Product:
- Neurostimulation Devices
- Neurosurgery Devices
- Interventional Neurology Devices
- Cerebrospinal Fluid Management Devices
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgery Centers
- Neurology Clinics
Breakup by Region:
• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa
REGIONAL INSIGHTS
North America is currently leading the global market, thanks to its robust healthcare infrastructure, early embrace of innovative neurology devices, and significant investment in clinical research. The rising prevalence of neurological disorders, an aging population, and supportive reimbursement systems are driving continuous market growth.
RECENT DEVELOPMENTS & NEWS
Recent trends highlight the merging of AI and robotics in neurology, with wearable neurostimulators and AI-powered imaging systems becoming quite popular. Additionally, minimally invasive surgical tools, such as catheter-based neurothrombectomy devices, are on the rise. Key industry players are pouring resources into research and development for regenerative and restorative therapies. Changes in policies that support reimbursement and the clinical adoption of advanced neuromodulation and neuroimaging devices are speeding up commercialization and improving access worldwide.
KEY PLAYERS
- Abbott Laboratories
- B. Braun
- Boston Scientific Corporation
- Integra LifeSciences
- LivaNova PLC
- Medtronic plc
- Nihon Kohden Corporation
- Penumbra Inc.
- Stryker Corporation
Ask Analyst for Customization: https://www.imarcgroup.com/request?type=report&id=6191&flag=C
If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No: +1-631-791-1145
